D-0605-2018 Class III Terminated
FDA drug recall D-0605-2018 was initiated by Renaissance Lakewood, LLC on Mar 2, 2018 and is designated Class III. Reason for recall: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability The recall status is terminated (terminated Apr 10, 2020). Affected quantity: 1277 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 4, 2018
- Initiation Date
- Mar 2, 2018
- Termination Date
- Apr 10, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1277 bags
Product description
Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10
Reason for recall
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
Distribution pattern
Nationwide
Code information
Lot A060644, May 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0605-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026